Catalent
Offers early development of small-molecule oral and injectable products. Its biologics business provides formulation, stability, and compatibility development for vials, prefilled syringes, and cartridges.
Corporate information
- Company entity
- Catalent
- Headquarters / principal office
- No verified public location identified
- Founded
- 2007 ↗
- Ownership / capital status
- AcquiredAcquired / taken private ↗
- Official corporate reference
- https://www.catalent.com/pharma/biologics/development/formulation-development ↗
- LinkedIn company page
- LinkedIn ↗ ↗
Profile review: 2026-11-04 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Public evidence snapshot
Offers early development of small-molecule oral and injectable products. Its biologics business provides formulation, stability, and compatibility development for vials, prefilled syringes, and cartridges.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.